Longboard Pharmaceuticals, Inc.
LBPHDelisted Dec 2, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001832168
Longboard Pharmaceuticals, Inc. was delisted on Dec 2, 2024; its insiders filed their last Form 4 on Dec 2, 2024; 125 institutions reported holding it in 13F filings for Q3 2024, worth $1.33B in total; Viking Global Investors was the only superinvestor holding it.
Holders of 5% or more of LBPH
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Longboard Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Longboard Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
48 Schedule 13D and 13G filings on Longboard Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 20256:39 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 0.00%0 shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 20254:50 PM ET | Viking Global Investors LPand 7 othersSuperinvestorViking Global Investors | 13G/A | 0.00%0 shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 11, 202512:05 PM ET | Zone II Healthcare Holdings, LLCand 30 others | 13G/A | 0.00%0 shares | –Below 5% | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Cormorant Asset Management, LP | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Price T Rowe Associates Inc | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13GOld format | – | – | – | SEC |
| Nov 8, 2024 | Farallon Capital Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 7, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Nov 7, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Nov 4, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Oct 22, 2024 | BlackRock, Inc. | 13GOld format | – | New | – | SEC |
| Jul 15, 2024 | Viking Global Investors LPSuperinvestorViking Global Investors | 13GOld format | – | New | – | SEC |
| Mar 11, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Cormorant Asset Management, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Point72 Asset Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Price T Rowe Associates Inc | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Prosight Management, LP | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | HBM Healthcare Investments (Cayman) Ltd. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 30, 2024 | Farallon Capital Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| Jan 29, 2024 | Pfizer Inc | 13D/AOld format | – | – | – | SEC |
| Jan 26, 2024 | Integrated Core Strategies (US) LLC | 13G/AOld format | – | – | – | SEC |
| Jan 12, 2024 | Ra Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Jan 10, 2024 | Pfizer Inc | 13D/AOld format | – | – | – | SEC |
| Nov 13, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Apr 20, 2023 | Prosight Management, LP | 13GOld format | – | New | – | SEC |
| Mar 27, 2023 | Pfizer Inc | 13D/AOld format | – | – | – | SEC |
| Mar 10, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | HBM Healthcare Investments (Cayman) Ltd. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Cormorant Asset Management, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Point72 Asset Management, L.P. | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Price T Rowe Associates Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 3, 2023 | Farallon Capital Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| Jan 25, 2023 | Integrated Core Strategies (US) LLC | 13G/AOld format | – | – | – | SEC |
| Mar 21, 2022 | Pfizer Inc | 13DOld format | – | New | – | SEC |
| Mar 10, 2022 | Arena Pharmaceuticals Inc | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Cormorant Asset Management, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Price T Rowe Associates Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 3, 2022 | Farallon Capital Management, L.L.C. | 13G/AOld format | – | – | – | SEC |
| Jan 12, 2022 | Integrated Core Strategies (US) LLC | 13GOld format | – | New | – | SEC |
| Apr 12, 2021 | FMR LLC | 13GOld format | – | New | – | SEC |
| Apr 12, 2021 | Price T Rowe Associates Inc | 13GOld format | – | New | – | SEC |
| Mar 26, 2021 | Cormorant Asset Management, LP | 13GOld format | – | New | – | SEC |
| Mar 25, 2021 | Farallon Capital Management, L.L.C. | 13GOld format | – | New | – | SEC |
| Mar 22, 2021 | HBM Healthcare Investments (Cayman) Ltd. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Longboard Pharmaceuticals, Inc. shares.
No Form 144 notices for Longboard Pharmaceuticals, Inc. are on file.